<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Esophagectomy has been the traditional therapy for high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and intramucosal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>New endoscopic approaches allow treatment of these lesions with esophageal preservation </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this study was to compare the outcome of endoscopic therapy with esophagectomy for high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and intramucosal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: A retrospective review was performed of <z:hpo ids='HP_0000001'>all</z:hpo> patients treated for high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> or intramucosal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> from 2001 to April 2010 </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Endoscopic therapy was performed in 40 patients (high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> = 22, intramucosal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> = 18) and esophagectomy in 61 patients (high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> = 13, intramucosal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> = 48) </plain></SENT>
<SENT sid="5" pm="."><plain>Endotherapy consisted of 102 endoscopic resections and 79 mucosal ablations (median 3 interventions per patient) </plain></SENT>
<SENT sid="6" pm="."><plain>In the endotherapy group, intramucosal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> was completely resected in <z:hpo ids='HP_0000001'>all</z:hpo> patients </plain></SENT>
<SENT sid="7" pm="."><plain>At last assessment, 10 patients have been converted to <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> without <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and 21 to no residual <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> </plain></SENT>
<SENT sid="8" pm="."><plain>Five patients have follow-up biopsy procedures pending after recent ablation, and esophagectomy was performed in 3 patients for failed endotherapy </plain></SENT>
<SENT sid="9" pm="."><plain>A laparoscopic Nissen fundoplication has been performed in 8 patients after eradication of <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> </plain></SENT>
<SENT sid="10" pm="."><plain>Esophagectomy resected the <z:e sem="disease" ids="C0151785" disease_type="Disease or Syndrome" abbrv="">mucosal disease</z:e> with negative margins in <z:hpo ids='HP_0000001'>all</z:hpo> patients </plain></SENT>
<SENT sid="11" pm="."><plain>Compared with esophagectomy, endotherapy was associated with significantly lower morbidity (39% vs 0; P &lt; .0001) and similar survival (94% at 3 years in both groups; median follow-up 34 months after esophagectomy vs 17 months after endotherapy; P = .0026) </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSIONS: Endoscopic therapy for high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> or intramucosal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> has lower morbidity than an esophagectomy and similar survival during short-term follow-up, but required multiple procedures in most patients </plain></SENT>
<SENT sid="13" pm="."><plain>Both therapies are appropriate options, but preservation of the esophagus allows the option of a fundoplication for reflux control, perhaps further improving long-term quality of life </plain></SENT>
</text></document>